D Osterkorn

Hydroxyethyl starch 130/0.42/6:1 for perioperative plasma volume replacement in children: preliminary results of a European prospective multicenter observational postauthorization safety study (PASS)

Robert Sümpelmann, Franz‐Josef Kretz, R. Gäbler et al. · Pediatric Anesthesia · 2008 · 70 citations

Efficacy, safety, and tolerability of long-term lipoprotein apheresis in patients with LDL- or Lp(a) hyperlipoproteinemia: Findings gathered from more than 36,000 treatments at one center in Germany

Franz Heigl, R Hettich, Norbert Lotz et al. · Atherosclerosis Supplements · 2015 · 57 citations

Metabolic Syndrome, Thrombosis, Health Policy +9

[The incidence of sudden hearing loss is greater than previously assumed].

Bernhard Olzowy, D Osterkorn, M. Suckfüll · PubMed · 2005 · 51 citations

Fibrinogen/LDL apheresis as successful second-line treatment of sudden hearing loss: a retrospective study on 217 patients

Franz Heigl, R Hettich, Markus Suckfuell et al. · Atherosclerosis Supplements · 2009 · 31 citations

Pediatric Otolaryngology, Successful Second-line Treatment, Audiology +8

Changes in acid‐base, electrolyte and hemoglobin concentrations during infusion of hydroxyethyl starch 130/0.42/6 : 1 in normal saline or in balanced electrolyte solution in children

Robert Sümpelmann, Lars Witt, MEIKE BRÜTT et al. · Pediatric Anesthesia · 2009 · 31 citations